Clinical Trial

Characterising the Neuromuscular Function of Post Stroke Patients

Study acronym: (cSTROKE)
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 10, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Strokes are a leading cause of death and disability in developed countries, with significant economic and social impacts. Defined by the WHO, strokes cause rapid and lasting disturbances in cerebral function. In the UK, strokes occur every five minutes, affecting 100,000 people annually and resulting in substantial physical impairments and financial costs. Although stroke-related deaths have decreased due to improved treatments and awareness, strokes remain a major cause of death and disability worldwide, especially in lower-income countries. Strokes typically cause unilateral deficits, leading to significant daily challenges and necessitating tailored rehabilitation strategies such as CIMT, FES, and VR Rehab. As the population ages, innovative neurorehabilitation approaches are essential to enhance functional recovery post-stroke. This pilot study aims to better understand the neuromuscular deficits caused by stroke to inform and improve future rehabilitation interventions, including the potential use of force accuracy training (FAT)
Trial Details
NCT Number NCT07013188
Lead Sponsor University of Nottingham
Conditions Stroke (CVA) or TIA
Enrollment 16 participants
Start Date 2024-06-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-10